A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Popular cities in Utah
Offering a robust healthcare network and esteemed research institutions, Utah is a significant hub for clinical trials. Leading centers like the University of Utah Health, Huntsman Cancer Institute, and the Intermountain Healthcare system are at the forefront of medical research and innovation. Utah's strong emphasis on research and its collaborative environment make it a prominent state for conducting impactful clinical trials.
Why choose Utah for clinical trials?
Utah offers distinct advantages for those participating in clinical trials. The state's diverse population, combined with its strong emphasis on community health and wellness, enriches the research landscape with a wide range of participants. Utah is also recognized for its innovative research environment, with a notable focus on advancing medical science and exploring cutting-edge treatments, particularly in pediatrics.
Choosing to participate in a clinical trial in Utah means contributing to crucial medical research while benefiting from a supportive and well-established clinical research system. Utah’s commitment to excellence in research, along with its collaborative approach and advanced facilities, makes it an excellent choice for those looking to engage in meaningful and impactful studies.
Common conditions studied in Utah
With leading healthcare institutions and strong research infrastructure, clinical research in Utah covers a wide range of medical conditions.
Cardiovascular diseases
With a high prevalence of heart disease in the state, Utah is a hub for cardiovascular disease research. Cardiovascular disease clinical trials in Utah seek to investigate a range of innovative treatments and interventions aimed at improving heart health and managing cardiovascular conditions.
Current trials include research on new medications for managing heart failure and hypertension, as well as advanced stent technologies and drug-eluting devices for coronary artery disease. Studies are also exploring novel therapies for atrial fibrillation, including new anticoagulants and catheter-based ablation techniques, in addition to regenerative medicine approaches like stem cell therapies.
Neurological disorders
In Utah, clinical trials for neurological disorders have become a key focus as the state sees increasing numbers of citizens living with neurodegenerative diseases such as Alzheimer’s disease. Trials here explore a range of innovative treatments and approaches designed to address various conditions affecting the nervous system.
Current trials include research on novel drug therapies for Alzheimer’s disease, focusing on disease-modifying treatments and cognitive enhancers. For Parkinson’s disease, studies are investigating new medications, gene therapies, and deep brain stimulation techniques to manage symptoms and potentially slow disease progression. Trials are also underway for multiple sclerosis (MS), evaluating new disease-modifying therapies and advanced imaging techniques to monitor disease activity and treatment response.
Cancer
Cancer clinical trials in Utah are actively exploring a variety of innovative treatments and therapeutic approaches aimed at improving patient outcomes. These clinical trials are particularly crucial in the state due to its high incidence of certain cancer types, for example, melanoma, and the growing need for advanced treatment options.
Current trials include studies on advanced immunotherapies, such as CAR-T cell therapy and checkpoint inhibitors, as well as new targeted therapies that focus on specific genetic mutations within tumors, offering more personalized treatment options for cancers like breast, lung, and prostate. Research is also being conducted on novel combinations of existing therapies, as well as new drug delivery systems and early detection methods.
Diabetes
With an increase in diabetes rates across the state, clinical research teams are placing an emphasis on investigating all types of the condition. Clinical trials for diabetes in Utah are actively investigating a variety of innovative treatments and management strategies aimed at improving outcomes for individuals with diabetes.
Current research includes trials on novel insulin formulations and delivery systems, such as advanced insulin pumps and continuous glucose monitoring systems, new pharmacological treatments for Type 1 and Type 2 diabetes, and emerging technologies like closed-loop insulin delivery systems and potential regenerative therapies.
Autoimmune diseases
Utah is a prime destination for autoimmune disease clinical research due to its leading institutions, including the University of Utah Health and Intermountain Healthcare. These centers are renowned for their state-of-the-art research facilities and expertise in autoimmune diseases.
Clinical trials for autoimmune diseases seek to develop new treatments and therapies for a range of conditions, including rheumatoid arthritis, lupus, and multiple sclerosis (MS). Current research includes trials on novel biologics and small molecule drugs that target specific immune system pathways involved in these diseases, as well as immunosuppressive agents, disease-modifying drugs, and stem cell treatments.
Mental Health Disorders
Mental health conditions are often researched in Utah, primarily due to the nation and state’s increasing awareness and emphasis on mental health issues. Clinical trials for mental health conditions investigate a variety of innovative treatments and therapeutic approaches to address several common and complex disorders.
Current research includes trials on new antidepressants and anxiolytics for conditions such as depression and generalized anxiety disorder. Studies are also exploring the potential of psychedelic therapies, like psilocybin and ketamine, for treatment-resistant depression and PTSD.
Clinical trials in the state are also focusing on advanced psychotherapies, including digital mental health interventions and novel cognitive-behavioral therapies, to enhance accessibility and efficacy in treating mental health disorders.
Local regulations and guidelines
Clinical trials are governed by a combination of federal, state, and institutional regulations in Utah to ensure participant safety and ethical conduct. At a federal level, the FDA oversees the approval process for investigational drugs and devices, while Institutional Review Boards (IRBs) at research institutions ensure each trial meets ethical standards and safeguards participant wellbeing. Informed consent is a key requirement, ensuring participants fully understand the risks and benefits before agreeing to participate.
The Utah Department of Health provides additional oversight, particularly in protecting vulnerable populations such as minors and the elderly. Institutions like the University of Utah Health and Intermountain Healthcare follow strict protocols related to patient care, data management, and privacy protection, adhering to HIPAA standards to secure participant data.
Benefits of participating in clinical trials
Participating in a clinical trial offers several benefits, including early access to new treatments and therapies that have not yet reached the general public. Throughout the process, participants receive dedicated care from top healthcare professionals, who provide thorough monitoring and specialized support during the study.
Additionally, involvement in clinical trials plays a crucial role in advancing medical research, potentially leading to significant breakthroughs in treatment. By joining a trial, individuals not only access innovative medical options but also contribute to the progress of science, helping to enhance future healthcare outcomes for others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
How to enroll in a clinical trial in Utah
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.